Brief: Theraclion: Announces Phase-2 Collaboration With University Of Virginia Cancer Center

Theraclion SA

01/06/2021 17:03

June 1 (Reuters) - Theraclion SA  ALTHER.PA :
    * UVA CANCER CENTER TO EXPAND USE OF THERACLION'S HIFU SYSTEM IN CANCER
TREATMENT
RESEARCH
    * ANNOUNCES A PHASE-2 COLLABORATION WITH UNIVERSITY OF VIRGINIA CANCER
CENTER
    * EXTENDS INVESTIGATION OF COMBINING HIFU WITH IMMUNOTHERAPY FROM LATE-STAGE
TO
THAT OF EARLY-STAGE BREAST CANCER
    * IF SUCCESSFUL, SUCH A PROTOCOL COULD OPEN A NEW WAY FOR TREATMENT

Source text for Eikon:  ID:nBw5V8Nysa 
Further company coverage:  ALTHER.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))